Tag Archives: Gilead

Unsuccessful in licensing talks, feds sue Gilead over PrEP-focused HIV patent

Gilead Sciences balked at licensing the U.S. government’s HIV-prevention patent rights, and now the feds are striking back. The Department of Health and Human Services sued Gilead for patent infringement Wednesday, saying the company and its HIV prophylaxis meds Truvada and Descovy reaped profits off hundreds of millions of dollars in taxpayer-funded research. The patent dust-up… Read More »

HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey

Pharma’s reputation is holding steady. That’s according to the annual patient group opinion report from PatientView, which found 41% who rated the pharma industry reputation as “excellent” or “good” in 2018, compared with a similar 43% in 2017. Fifty-three percent of patient groups also rated the industry as excellent or good for the making of… Read More »